Fulcrum Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Fulcrum Therapeutics by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $165k | 25k | 6.75 |
2023-09-30 | $109k | 25k | 4.44 |
2023-06-30 | $81k | 25k | 3.30 |
2023-03-31 | $403k | 141k | 2.85 |
2022-12-31 | $836k | 115k | 7.28 |
2022-09-30 | $751k | 93k | 8.10 |
2022-06-30 | $422k | 86k | 4.91 |
2022-03-31 | $1.7M | 72k | 23.65 |
2021-12-31 | $1.2M | 71k | 17.69 |
2021-09-30 | $1.9M | 67k | 28.21 |
2021-06-30 | $569k | 54k | 10.48 |
2021-03-31 | $514k | 44k | 11.78 |
2020-12-31 | $434k | 37k | 11.73 |
2020-09-30 | $260k | 33k | 7.95 |
2020-06-30 | $546k | 30k | 18.32 |
2020-03-31 | $320k | 27k | 11.95 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management